vTv Therapeutics Inc. — Form 8-K

vTv Therapeutics Inc. adopted a Third Amended and Restated By-Laws document, effective as of the filing date. The by-laws establish governance procedures for stockholder meetings, director nominations, board operations, and officer duties. Key provisions include a 33.4% quorum threshold for stockholder meetings, director nomination windows (120-90 days before annual meetings), a requirement that director nominees hold minimum 1,000 shares of Class A common stock, and an exclusive federal forum provision for Securities Act claims. No specific financial transactions, dollar amounts, or material business changes are disclosed in this governance filing.